RISANKIZUMAB EFFICACY/SAFETY IN MODERATE-TO-SEVERE PLAQUE PSORIASIS: 16-WEEK RESULTS FROM IMMHANCE

RISANKIZUMAB EFFICACY/SAFETY IN MODERATE-TO-SEVERE PLAQUE PSORIASIS: 16-WEEK RESULTS FROM IMMHANCE Meeting Abstract

sustainable development goals

SDG 03: Good Health and Well-being

publication date

January 1, 2018

webpage

Web of Science

published in

ACTA DERMATO-VENEREOLOGICA Journal

start page

30

end page

30

volume

98